scholarly journals Inflammatory Myofibroblastic Tumor of the Breast

2015 ◽  
Vol 2015 ◽  
pp. 1-5 ◽  
Author(s):  
Christos Markopoulos ◽  
Petros Charalampoudis ◽  
Evangelia Karagiannis ◽  
Zoh Antonopoulou ◽  
Dimitrios Mantas
Keyword(s):  
Natural History ◽  
Female Patient ◽  
Inflammatory Myofibroblastic Tumor ◽  
Metastatic Potential ◽  
Breast Conserving Surgery ◽  
Rare Entity ◽  
Inflammatory Myofibroblastic Tumors ◽  
Postmenopausal Female

Inflammatory myofibroblastic tumors (IMTs) of the breast represent extremely rare lesions. Due to the scarcity of reports, their natural history, recurrence, and metastatic potential remain poorly defined. We report on a case of a primary breast IMT in a postmenopausal female patient treated successfully with breast conserving surgery and review the literature pertaining to this rare entity.

scholarly journals Diffuse Melanosis and Ascites due to Metastatic Malignant Melanoma

2008 ◽  
Vol 8 ◽  
pp. 556-557 ◽  
Author(s):  
Elena Sendagorta ◽  
Angel Pizarro ◽  
Marta Feito ◽  
Matias Mayor ◽  
Paloma Ramírez ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Metastatic Melanoma ◽  
Female Patient ◽  
Metastatic Malignant Melanoma ◽  
Current Evidence ◽  
Rare Entity ◽  
Skin Hyperpigmentation

We present a female patient who developed mucosal and skin hyperpigmentation due to metastatic malignant melanoma. Diffuse cutaneus melanosis is a rare entity that complicates a small percentage of metastatic melanomas, confering a fatal prognosis. We discuss briefly the current evidence on pathogenesis of melanosis arising from metastatic melanoma.

scholarly journals Inflammatory myofibroblastic tumor of the lung: A rare entity

2020 ◽  
Vol 31 ◽  
pp. 101287
Author(s):  
Yosra Braham ◽  
Asma Migaou ◽  
Manel Njima ◽  
Asma Achour ◽  
Ahmed Ben Saad ◽  
...  
Keyword(s):  
Inflammatory Myofibroblastic Tumor ◽  
Rare Entity

scholarly journals RARE-23. PRIMARY INTRA-AXIAL CENTRAL NERVOUS SYSTEM INFLAMMATORY MYOFIBROBLASTIC TUMOR, ALK NEGATIVE: A RARE ENTITY

2018 ◽  
Vol 20 (suppl_6) ◽  
pp. vi241-vi241
Author(s):  
Nicholas Pflederer ◽  
John Gross ◽  
Julia Bridge ◽  
Cam Nguyen ◽  
Thomas Ruma
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Inflammatory Myofibroblastic Tumor ◽  
Rare Entity

scholarly journals IMFT of the sigmoid colon: a case report

2019 ◽  
Vol 2019 (11) ◽  
Author(s):  
Narendra Pandit ◽  
Tek Narayan Yadav ◽  
Deepa Shrestha ◽  
Purbesh Adhikari ◽  
Laligen Awale
Keyword(s):  
Case Report ◽  
Sigmoid Colon ◽  
Inflammatory Myofibroblastic Tumor ◽  
Stromal Tumor ◽  
Rare Entity ◽  
Radiological Findings ◽  
Bleeding Per Rectum ◽  
Uncommon Case ◽  
Inflammatory Infiltrates

Abstract Inflammatory myofibroblastic tumor (IMFT) of the colon is a very rare entity, characterized by proliferation of myofibroblast cells admixed with inflammatory infiltrates. The entity was first described in the late 1990s, and since then less than 30 cases have been described. It frequently mimics other neoplasm of the colon, such as adenocarcinoma, lymphoma and stromal tumor, and is very difficult to clinch the diagnosis preoperatively based on the clinical and radiological findings. Here, we discuss an uncommon case of sigmoid IMFT in a 35-year old male, presenting with bleeding per rectum and managed successfully by colectomy.

A 56-year-old female patient with facio-oculo-acoustico-renal syndrome (FOAR) syndrome. Report on the natural history and of a novel mutation

2009 ◽  
Vol 52 (5) ◽  
pp. 341-343 ◽  
Author(s):  
Samantha Stora ◽  
Martine Conte ◽  
Eliane Chouery ◽  
Sami Richa ◽  
Nadine Jalkh ◽  
...  
Keyword(s):  
Natural History ◽  
Female Patient ◽  
Novel Mutation ◽  
Syndrome Report

scholarly journals Dilated Cardiomyopathy Compatible With Sarcoidosis Presenting with Syncope Due to Torsades de Pointes: a Case Report

2021 ◽  
Vol 34 (1) ◽  
pp. 32-37
Author(s):  
Carollina Fernandes Tinoco ◽  
Nathalia Rodrigues Perrenoud Branca ◽  
Gabriela Domingues Carvalho ◽  
Lívia Silva de Paula Faria ◽  
Erivelton Alessandro do Nascimento
Keyword(s):  
Case Report ◽  
Natural History ◽  
Dilated Cardiomyopathy ◽  
Female Patient ◽  
Diagnostic Tests ◽  
Clinical Presentation ◽  
Cardiac Sarcoidosis ◽  
Torsades De Pointes ◽  
Unknown Etiology ◽  
Granulomatous Disease

Sarcoidosis is a multisystemic noncaseating granulomatous disease of unknown etiology. Cardiac sarcoidosis clinical presentation is diverse, and syncope is one of the possible primary events. Due to its variable natural history and initial presentation associated with lacking sensitive and specific diagnostic tests, it still represents a challenging diagnosis. This article presents the case of a 51-year-old female patient with intermittent syncope events associated with torsades de pointes and dilated cardiomyopathy compatible with sarcoidosis.

How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature

2019 ◽  
Vol 26 (4) ◽  
pp. 1011-1018 ◽  
Author(s):  
Ozkan Alan ◽  
Okan Kuzhan ◽  
Sinan Koca ◽  
Tugba Akin Telli ◽  
Tugba Basoglu ◽  
...  
Keyword(s):  
Anaplastic Lymphoma Kinase ◽  
Inflammatory Myofibroblastic Tumor ◽  
Kinase Inhibitor ◽  
Case Reports ◽  
Tumor Control ◽  
Anaplastic Lymphoma Kinase Inhibitor ◽  
Anaplastic Lymphoma ◽  
Short Period ◽  
Inflammatory Myofibroblastic Tumors

Introduction Inflammatory myofibroblastic tumor is a rare disease which is typically seen in children and young adults. Approximately half of the inflammatory myofibroblastic tumors contain translocations that result in over-expression of anaplastic lymphoma kinase gene. Herein, we present two anaplastic lymphoma kinase-positive cases with long-term remission with crizotinib. We do not know how long these therapies need to be continued. Case reports We present two cases of inflammatory myofibroblastic tumor treated with anaplastic lymphoma kinase inhibitor therapies: an 8-year-old Turkish boy and a 21-year-old Caucasian man. Management and outcome Two cases, both with good tumor control under crizotinib, but one who progressed on drug holiday, responded again to the same drug, and had a very short period of response after restarting crizotinib. Conclusion A molecular-targeted drug (anaplastic lymphoma kinase inhibitor) was found to be extremely effective as selective therapy for inflammatory myofibroblastic tumor with anaplastic lymphoma kinase translocation. Here, we want to emphasize the continuation of this treatment after achieving a good response until progression or a major side effect.

scholarly journals Odontogenic myxofibroma- Report of a rare entity

2016 ◽  
Vol 6 (12) ◽  
pp. 1043-1045
Author(s):  
P Poudel ◽  
B Bajracharya ◽  
S Bhattacharya ◽  
D Bajracharya ◽  
S Singh ◽  
...  
Keyword(s):  
Female Patient ◽  
Recurrence Rate ◽  
Rare Case ◽  
Benign Tumor ◽  
Final Diagnosis ◽  
High Recurrence Rate ◽  
Rare Entity ◽  
Odontogenic Myxoma ◽  
Immunohistochemical Examination ◽  
Rare Benign Tumor

Odontogenic myxofibroma is a rare, benign tumor, which is considered to be the variant of odontogenic myxoma. It is locally infiltrative, aggressive and has high recurrence rate. Only 24 specific cases of myxofibroma have been reported since 1950 and only two cases have been reported with excessive calcifications till 2012. Here, we report a rare case of Odontogenic myxofibroma with calcifications in 53 years old female patient who presented with the chief complain of swelling. The final diagnosis of Odontogenic myxofibroma was established after histopathological and immunohistochemical examination.

Sign in / Sign up

Export Citation Format

Share Document